Yingying Zhang

No ORCID on file · 5 papers in corpus · active 2018-2025

Study types

  • article 4
  • review 1

Condition tags

  • adenomyosis 3
  • endometriosis 2
article 2025
Human Reproduction ·doi:10.1093/humrep/deaf042

STUDY QUESTION: What are the unrecognized risk factors for recurrent implantation failure (RIF) as defined in the ESHRE recommendation? SUMMARY ANSWER: Anti-Müllerian hormone (AMH) is the strongest predictor for RIF, followed by chronic en…

review 2022
BioMed research international ·doi:10.1155/2022/7663379

EMs is a kind of benign disease with certain malignant behaviors. The adhesion, invasive growth, and angiogenesis of ectopic endometrial cells are the pathological basis of EMs occurrence, but its etiology and pathogenesis have not been com…

article 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00318

Introduction:Although pre-treatment with a GnRH agonist can reduce the size of adenomyosis lesions, the supra-physiological hormone level induced by controlled ovarian hyperstimulation (COH) may negate the usefulness of the GnRH agonist in …

article 2018
International journal of clinical and experimental pathology

OBJECTIVE: To examine the association of coexistence of adenomyosis and endometrial carcinoma on tumor characteristics and survival outcome of patients. METHODS: Clinical and pathological data were retrospectively reviewed from 1584 patient…

article 2018